XXXX for spinal anesthesia: a retrospective analysis.

@entity1 @entity16 @entity3303 @entity4487
BACKGROUND: Recent volunteer and clinical studies of @entity4487 (CP) have evaluated its use for outpatient spinal anesthesia. This retrospective review describes the discharge characteristics and reported side effects of spinal CP in a large number of @entity1 undergoing outpatient procedures. METHODS: All @entity1 who received spinal anesthesia for ambulatory procedures over a 20-month period were accessed using computer-generated reports. Charts from 601 anesthetics were analyzed for spinal drug used, block characteristics, side effects and discharge data. RESULTS: CP was the most frequently used spinal anesthetic (84% of cases, n=503) for outpatient procedures. CP (median dose 40 mg, range 20-60 mg) times from injection to ambulation and discharge were 107  24 and 171  45 min, respectively. @entity3303 (median dose 60 mg, range 30-100 mg, n=84) times from injection to ambulation and discharge were 155  40 and 224  57 min, respectively (P<0.05). The incidence of urinary retention, the most common side effect, was similar in both groups. There were no reports of transient @entity16 . CONCLUSIONS: For ambulatory @entity1 at our institution, the time to achievement of discharge criteria was significantly reduced with CP 40 vs. @entity3303 60 mg. There have been no reports of perioperative @entity16 with the introduction of CP as a spinal anesthetic at our institution.
